InMed Pharmaceuticals (INM)

• Market cap: $5.14M
• 1 day: 3.33%
• 5 days: 5.44%
• 1 month: -9.88%
• 3 months: 124.15%
• 6 months: 26.02%
• Year to date: 38.39%
• 1 year: -59.95%
• 5 years: -99.89%
• 10 years: -99.9%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Employees: 13